Redmond’s EndoGastric Solutions (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), announced that industry veteran Michael K. Burke has been named chief financial officer. Burke is a seasoned financial executive with more than 30 years of experience.
“I am excited to join EGS at such an important time in the company’s development,” Burke stated. “Since receiving our CPT code designation, millions of individuals suffering from painful acid reflux symptoms will now have a pathway to the TIF procedure — a safe and effective treatment option not previously available to them. I look forward to working alongside EGS’s leadership team in establishing our transoral, incisionless procedure as a standard of care for a subset of GERD patients that would significantly benefit from this treatment option.”
EGS recently announced that the Federal Register has posted coding and payment information specific to the new Current Procedural Terminology (CPT), allowing patients to more easily receive access to treatment for GERD. Physicians and hospitals will be able to reference CPT Code 43210 EGD esophagogastric fundoplasty and APC 5331 Complex GI Procedures for TIF procedures as of Jan. 1, 2016.
“Michael is a vital addition to the EGS senior executive leadership team,” said Skip Baldino, president and CEO of EndoGastric Solutions. “Michael brings to EGS deep financial and operational experiences that will serve us well as we continue our efforts to gain greater adoption of our proprietary TIF technology as a beneficial treatment option for a subset of the GERD patient population we serve. As EGS continues to build our franchise with a balanced commercial approach involving robust clinical data expansion, ongoing product development, and increased commercial investments — we are thrilled to have someone of Michael’s caliber spearheading the company’s financial direction.”
Burke has held several leadership positions in finance. He most recently served as senior vice president and chief financial officer of Landauer, Inc., a leading global provider of technical and analytical services to the healthcare sector. Prior to this, Burke was the senior vice president and chief financial officer of Albany International Corp., and as the executive vice president and chief financial officer of Intermagnetics General Corporation, a medical device company focused on magnetic resonance imaging. Burke graduated from Lake Forest College with a bachelor’s degree in economics and completed graduate studies at The Wharton School of the University of Pennsylvania.
